0001562180-24-005595.txt : 20240703
0001562180-24-005595.hdr.sgml : 20240703
20240703161433
ACCESSION NUMBER: 0001562180-24-005595
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240701
FILED AS OF DATE: 20240703
DATE AS OF CHANGE: 20240703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Eatwell Victoria
CENTRAL INDEX KEY: 0002009135
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40791
FILM NUMBER: 241100278
MAIL ADDRESS:
STREET 1: C/O 2SEVENTY BIO, INC.
STREET 2: 60 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 2seventy bio, Inc.
CENTRAL INDEX KEY: 0001860782
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 863658454
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02210
BUSINESS PHONE: 339-499-9300
MAIL ADDRESS:
STREET 1: 60 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02210
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-07-01
false
0001860782
2seventy bio, Inc.
TSVT
0002009135
Eatwell Victoria
60 BINNEY STREET
CAMBRIDGE
MA
02142
false
true
false
false
Chief Financial Officer
false
Common Stock
2024-07-01
4
A
false
245864.00
0.00
A
341344.00
D
Common Stock
2024-07-02
4
S
false
12.00
4.0178
D
341332.00
D
This restricted stock unit award vests ratably over a two-year period in annual installments with the first installment vesting on July 1, 2025, subject to the Reporting Person's continued service through the applicable vesting date.
Shares were sold to cover tax withholding obligations incurred in connection with the vesting of restricted stock units.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.02, inclusive. The Reporting Person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Iya Kessler, Attorney-in-Fact
2024-07-03